AptarGroup, Inc. Q1 2026 Earnings Release

AptarGroup, Inc. reported Q1 2026 results with increased sales but decreased net income and earnings per share compared to the prior year. Sales increased by 11% to $982.9 million, while reported net income decreased by 8% to $73 million, and reported earnings per share decreased by 4% to $1.12. Adjusted earnings per share were $1.19, an 8% decrease. The company saw strong growth in its injectables division, driven by demand for GLP-1 and biologics, and positive contributions from consumer dispensing. However, the prescription division was impacted by emergency medicine destocking. Aptar returned $131 million to shareholders through share repurchases and dividends. The company announced Gael Touya as its next CEO, effective September 1, 2026. Aptar expects Q2 2026 adjusted earnings per share to be in the range of $1.32 to $1.40.